About Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect
Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect is a rare disease catalogued by Orphanet (ORPHA:466784). It is associated with the SLC25A26 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect trials.
Search ClinicalTrials.gov for "Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect" or filter by Orphanet code ORPHA:466784 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect. Updated daily.